Skip to main content
. 2022 Jan 3;23(1):52–59. doi: 10.3348/kjr.2021.0266

Table 1. Patient Characteristics.

Characteristics Patients with HAO (n = 40) Patients without HAO (n = 94) P
Age, year 55.2 ± 9.7 (21–74) 51.7 ± 10.6 (19–74) 0.079
Sex, male:female 24:16 64:30 0.369
Body weight, kg 65.8 ± 12.7 (48.3–102.0) 68.5 ± 17.1 (37.0–119.3) 0.358
Body mass index, kg/m2 24.6 ± 4.6 (18.7–40.7) 24.8 ± 4.9 (14.6–39.1) 0.820
Transplantation type 0.227
DDLT 9 31
LDLT (dual grafts) 31 (4) 63 (36)
Doppler abnormality type < 0.001
No detectable flow 36 35
Tardus parvus waveform 4 59
Laboratory findings
AST, IU/L
D (-1) 201.9 ± 239.8 (11–952) 240.1 ± 569.1 (11–3482) 0.687
D (0) 363.5 ± 470.1 (19–2553) 287.4 ± 557.7 (11–3780) 0.452
AST ratio 4.7 ± 12.2 (0.2–77.0) 2.5 ± 3.9 (0.2–20.6) 0.190
ALT, IU/L
D (-1) 180.5 ± 195.0 (6–991) 215.6 ± 385.7 (6–2403) 0.591
D (0) 356.8 ± 365.7 (8–1764) 239.5 ± 362.2 (10–2413) 0.090
ALT ratio 5.8 ± 17.9 (0.3–113.0) 2.9 ± 5.3 (0.5–28.8) 0.153

Values are mean ± standard deviation with the range in parentheses or the patient number. ALT = alanine aminotransferase, ALT ratio = ALT value of D (0) divided by D (-1) value, AST = aspartate transaminase, AST ratio = AST value of D (0) divided by D (-1) value, DDLT = deceased donor liver transplant, D (0) = the day of CT scan, D (-1) = the day before CT scan, HAO = hepatic artery occlusion, LDLT = living donor liver transplant